AN2 Therapeutics
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Purchase
READNOUR ROBIN SHANE director
 Common Stock 5,000 $1.49 $7,470
Purchase
READNOUR ROBIN SHANE director
 Common Stock 5,000 $1.49 $7,460
Purchase
READNOUR ROBIN SHANE director
 Common Stock 18,483 $1.43 $26,412
Purchase
READNOUR ROBIN SHANE director
 Common Stock 12,289 $1.43 $17,573
Purchase
READNOUR ROBIN SHANE director
 Common Stock 6,517 $1.45 $9,430
Purchase
READNOUR ROBIN SHANE director
 Common Stock 12,711 $1.45 $18,367
Purchase
READNOUR ROBIN SHANE director
 Common Stock 25,000 $1.42 $35,425
Purchase
READNOUR ROBIN SHANE director
 Common Stock 25,000 $1.42 $35,425
Purchase
ZAKRZEWSKI JOSEPH S director
 Common Stock 2,000 $1.4 $2,800
Purchase
READNOUR ROBIN SHANE director
 Common Stock 12,500 $1.39 $17,425
Purchase
READNOUR ROBIN SHANE director
 Common Stock 12,500 $1.39 $17,413
Purchase
READNOUR ROBIN SHANE director
 Common Stock 25,000 $1.16 $29,000
Purchase
READNOUR ROBIN SHANE director
 Common Stock 25,000 $1.16 $28,875
Purchase
READNOUR ROBIN SHANE director
 Common Stock 75,000 $1.03 $77,550
Purchase
READNOUR ROBIN SHANE director
 Common Stock 75,000 $1.04 $77,700
Purchase
ZAKRZEWSKI JOSEPH S director
 Common Stock 5,000 $1.01 $5,050
Purchase
ZAKRZEWSKI JOSEPH S director
 Common Stock 20,000 $1 $20,000
Purchase
EASOM ERIC director, officer: Chief Execut..
 Common Stock 50,000 $1 $49,950
Purchase
LEONARD BRADEN MICHAEL 10 percent owner
 Common Stock 1,500,000 $1.04 $1,560,000
Sale
RA CAPITAL MANAGEMENT, L.P. 10 percent owner
 Common Stock 3,410,335 $1.08 $3,683,162
Sale
RA CAPITAL MANAGEMENT, L.P. 10 percent owner
 Common Stock 114,759 $1.08 $123,940
Sale
ZAKRZEWSKI JOSEPH S director
 Common Stock 100,000 $19.11 $1,911,400
Sale
AZIZ KABEER director
 Common Stock 84,093 $19.65 $1,652,427
Sale
AZIZ KABEER director
 Common Stock 15,907 $19.65 $312,573
Sale
ADJUVANT GLOBAL HEALTH TECHNOLOGY FUND, L.P. 10 percent owner
 Common Stock 84,093 $19.65 $1,652,427
Sale
ADJUVANT GLOBAL HEALTH TECHNOLOGY FUND, L.P. 10 percent owner
 Common Stock 15,907 $19.65 $312,573
Sale
READNOUR ROBIN SHANE director
 Common Stock 719 $21.91 $15,753
Sale
READNOUR ROBIN SHANE director
 Common Stock 706 $21.92 $15,476
Sale
READNOUR ROBIN SHANE director
 Common Stock 1,800 $21.92 $39,456
Sale
READNOUR ROBIN SHANE director
 Common Stock 1,869 $21.93 $40,987
Option
KRAUSE KEVIN MICHAEL officer: Chief Strategy Officer
 Stock Option (right to buy) 2,417 $0.42 $1,015
Option
KRAUSE KEVIN MICHAEL officer: Chief Strategy Officer
 Stock Option (right to buy) 5,000 $6.6 $33,000
Option
KRAUSE KEVIN MICHAEL officer: Chief Strategy Officer
 Common Stock 5,000 $6.6 $33,000
Option
KRAUSE KEVIN MICHAEL officer: Chief Strategy Officer
 Common Stock 2,417 $0.42 $1,015
Sale
KRAUSE KEVIN MICHAEL officer: Chief Strategy Officer
 Common Stock 7,417 $20.14 $149,371
Option
KRAUSE KEVIN MICHAEL officer: Chief Strategy Officer
 Stock Option (right to buy) 2,583 $0.42 $1,085
Option
KRAUSE KEVIN MICHAEL officer: Chief Strategy Officer
 Common Stock 2,583 $0.42 $1,085
Sale
KRAUSE KEVIN MICHAEL officer: Chief Strategy Officer
 Common Stock 2,583 $20.12 $51,967
Sale
EASOM ERIC director, officer: Chief Execut..
 Common Stock 2,777 $20.1 $55,804
Sale
ADJUVANT GLOBAL HEALTH TECHNOLOGY FUND, L.P. 10 percent owner
 Common Stock 1,522 $16.15 $24,574
Sale
ADJUVANT GLOBAL HEALTH TECHNOLOGY FUND, L.P. 10 percent owner
 Common Stock 288 $16.15 $4,650
Sale
AZIZ KABEER director, 10 percent owner:
Common Stock 1,522 $16.15 $24,574
Sale
AZIZ KABEER director, 10 percent owner:
Common Stock 288 $16.15 $4,650
Sale
ADJUVANT GLOBAL HEALTH TECHNOLOGY FUND, L.P. 10 percent owner
 Common Stock 4,770 $16.07 $76,654
Sale
ADJUVANT GLOBAL HEALTH TECHNOLOGY FUND, L.P. 10 percent owner
 Common Stock 902 $16.07 $14,495
Sale
AZIZ KABEER director, 10 percent owner:
Common Stock 4,770 $16.07 $76,654
Sale
AZIZ KABEER director, 10 percent owner:
Common Stock 902 $16.07 $14,495
Sale
AZIZ KABEER director, 10 percent owner:
Common Stock 15,764 $16.28 $256,638
Sale
AZIZ KABEER director, 10 percent owner:
Common Stock 83,337 $16.28 $1,356,726
Sale
ADJUVANT GLOBAL HEALTH TECHNOLOGY FUND, L.P. 10 percent owner
 Common Stock 83,337 $16.28 $1,356,726

Showing 1 to 50 of 112 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.

Similar companies insider trading: